share

n-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-(Phenylsulfonyl)-4-Quinazolinamine CAS NO 945553-94-6


Unit Price:

CAS No.:945553-94-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

n-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-(Phenylsulfonyl)-4-Quinazolinamine is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in targeted drug discovery, particularly for kinase inhibition. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of novel therapeutic agents.

Application

  • Pharmaceutical Intermediate: A key building block in the synthesis of novel quinazoline-based kinase inhibitors for oncology research.
  • Biochemical Research: Used as a reference standard or active probe in enzymatic assays and structure-activity relationship (SAR) studies.
  • Preclinical Development: Serves as a crucial material for process chemistry development, formulation studies, and toxicology assessments of candidate drugs.
  • Academic Research: Employed in university and institutional labs for medicinal chemistry projects focusing on fluorinated and sulfonylated heterocycles.
  • Custom Synthesis: A starting point for contract research organizations (CROs) and CDMOs performing bespoke synthesis for client drug discovery programs.

Basic Information

Product Name n-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-(Phenylsulfonyl)-4-Quinazolinamine
CAS No. 945553-94-6
Molecular Formula C20H12ClFN4O4S
Molecular Weight 458.85 g/mol
Synonyms 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-nitro-7-(phenylsulfonyl)-; 945553-94-6; N-(3-Chloro-4-fluorophenyl)-6-nitro-7-(phenylsulfonyl)quinazolin-4-amine; 7-(Benzenesulfonyl)-N-(3-chloro-4-fluorophenyl)-6-nitro-4-quinazolinamine; EGFR Inhibitor Intermediate; Kinase Inhibitor Intermediate; 6-Nitro-7-(phenylsulfonyl)-N-(3-chloro-4-fluorophenyl)-4-quinazolinamine
EINECS Contact for details

Quality Control

Our n-(3-Chloro-4-Fluorophenyl)-6-Nitro-7-(Phenylsulfonyl)-4-Quinazolinamine is manufactured under strict GMP-like conditions to ensure batch-to-batch consistency and high purity suitable for research applications. Every lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to ICH guidelines for stability and impurity characterization to support regulatory filings.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture uptake. For long-term storage, consider storage under an inert atmosphere.

Specification

Item Specification
Appearance Yellow to light brown powder
Identification (IR) Conforms to structure
Identification (HPLC) Conforms to reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC) Complies with ICH Q3C
Heavy Metals < 20 ppm
Loss on Drying ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.